{"id":"F2016L00260","name":"Amendment Statement of Principles concerning aplastic anaemia No. 31 of 2016","slug":"amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":94158,"registerId":"commonwealth-F2016L00260-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Amendment Statement of Principles concerning aplastic anaemia No. 31 of 2016","content":"![RMA-Red](image.001.jpeg)\n\nAmendment Statement of Principles\n\nconcerning\n\nAPLASTIC ANAEMIA\n\nNo. 31 of 2016\n\nfor the purposes of the\n\nVeterans’ Entitlements Act 1986\n\nand\n\nMilitary Rehabilitation and Compensation Act 2004\n\n1.  This Instrument may be cited as Amendment Statement of Principles concerning aplastic anaemia No. 31 of 2016.\n2.  The Repatriation Medical Authority amends, under subsection 196B(8) of the Veterans’ Entitlements Act 1986, Statement of Principles concerning aplastic anaemia Instrument No. 50 of 2012, by:\n\n(A) Replacing existing factor \"(g)\" in clause 6 as follows:\n\n\"(g) being exposed to benzene as specified on at least 30 days within the six months before the clinical onset of aplastic anaemia; or\"; and\n\n(B) Replacing the definition of \"being exposed to benzene\" in clause 9 with the definition of \"being exposed to benzene as specified\" as follows:\n\n'\"being exposed to benzene as specified\" means:\n\n    (a) having cutaneous contact with liquids containing benzene greater than 5% by volume; or\n    (b) ingesting liquids containing benzene greater than 5% by volume; or\n    (c) inhaling benzene vapour where such exposure occurs at an ambient 8-hour time-weighted average benzene concentration exceeding five parts per million;'.\n\n3. The amendments made by this instrument apply to all matters to which Instrument No. 50 of 2012, section 120A of the Veterans’ Entitlements Act 1986 and section 338 of the Military Rehabilitation and Compensation Act 2004 apply.\n\n4. The amendments made by this instrument take effect from 4 April 2016.\n\nDated this fourth day of March 2016\n\n![](image.002.png)The Common Seal of the )\n\nRepatriation Medical Authority )\n\nwas affixed at the direction of: )\n\nPROFESSOR NICHOLAS SAUNDERS AO\n\nCHAIRPERSON","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2356},"content_quality":"ok","complexity_score":3,"scope_assessment":{"changed":false,"description":"The amendment maintains the original scope of establishing causal factors for aplastic anaemia in veterans' compensation claims. While it narrows the evidentiary requirements for benzene exposure by replacing a general definition with precise technical thresholds, it does not expand the instrument to cover new diseases, new claimant classes, or additional administrative schemes."},"complexity_factors":["Technical occupational health definitions requiring specific chemical concentrations (5% by volume for liquids, 5 ppm 8-hour time-weighted average for vapours)","Temporal calculation requirement linking exposure duration (30 days) to clinical onset window (6 months)","Cross-references to parent instrument (Statement of Principles No. 50 of 2012) and two enabling Acts"],"plain_english_summary":"This amendment tightens the medical criteria for veterans seeking compensation for aplastic anaemia, requiring more specific proof that benzene exposure caused the disease. It applies to Defence personnel claiming under the Veterans' Entitlements Act 1986 or MRCA 2004.\n\nClaimants must show exposure on at least 30 days within the six months before symptoms and meet strict thresholds (skin/swallowing >5% benzene or inhalation >5 ppm over an 8‑hour shift)."}},"importantCases":[],"_links":{"self":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016","history":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016/history","analysis":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016/analysis","conflicts":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016/conflicts","importantCases":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016/important-cases","documents":"/api/acts/amendment-statement-of-principles-concerning-aplastic-anaemia-no-31-of-2016/documents"}}